Lack of Efficacy of Phenytoin in Recessive Dystrophic Epidermolysis Bullosa

Authors:
  • RSRobert S. Stern
    Robert S. Stern
  • ALAndrew N. Lin
    Andrew N. Lin
  • DCD. Martin Carter
    D. Martin Carter
  • TGthe Epidermolysis Bullosa Study Group*
    the Epidermolysis Bullosa Study Group*

Abstract
Recessive dystrophic epidermolysis bullosa is an uncommon, severely disabling, heritable disorder characterized by abnormal fragility of the skin. Open trials have suggested that phenytoin is an effective treatment, and this therapy is now widely used.

This publication has 10 references indexed in Scilit: